Objective To describe Norwegian pharmacies’ involvement in diabetes care, to investigate pharmacists’ views on future services and to investigate whether the recommendations in the Norwegian diabetes declaration for pharmacies have been implemented. Setting Hospital and community pharmacies in Norway. Method All 543 pharmacies in Norway, of which 511 were community pharmacies and 32 were hospital pharmacies, received a link to a web-based questionnaire. One pharmacist from each pharmacy was asked to complete the questionnaire. The questionnaire covered subjects ranging from the diabetes declaration and the pharmacists’ views on which services the pharmacy should offer in the future, to demographic characteristics. Results In total 358 (66%) questionnaires were completed. The diabetes declaration was read by 37% of the pharmacists. Almost all pharmacies complied with the declarations’ recommendations regarding glucose monitoring services. Twenty four percent of the pharmacies could offer medication reviews, and roughly 10% could offer screening for undiagnosed diabetes. Counseling on lifestyle issues was the least implemented recommendation. Eighty one percent of the pharmacists reported a wish to expand their services towards diabetes patients. Services in regard to glucose monitoring had the highest score, however the views on which services should be offered varied a great deal. Already performing a service increased the chance of the pharmacist being positive towards offering it. Conclusion Norwegian pharmacists report that they are involved in a wide range of diabetes related services, although only 37% report to have read the diabetes declaration. The pharmacists generally wish to actively support patients with diabetes, and further research should concentrate on identifying the areas where their involvement is most productive.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296(4):427–40.
Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001;(1):CD001481.
Intensive diabetes management: implications of the DCCT, UKPDS. Diabetes Educ 2002;28(5):735–40.
West D, Blevins MA, Brech D, Stotts F, Gardner S. A multidisciplinary approach in a community pharmacy can improve outcomes for diabetes patients. Diabetes Educ 2003;29(6):962–8.
Schapansky LM, Johnson JA. Pharmacists’ attitudes toward diabetes. J Am Pharm Assoc (Wash ) 2000;40(3):371–7.
Johnson JA. Self-efficacy theory as a framework for community pharmacy-based diabetes education programs. Diabetes Educ 1996;22(3):237–41.
Petkova VB, Petrova GI. Pilot project for education of patients with type 2 diabetes by pharmacists. Acta Diabetol 2006;43(2):37–42.
Sarkadi A, Rosenqvist U. Study circles at the pharmacy–a new model for diabetes education in groups. Patient Educ Couns 1999;37(1):89–96.
Cranor CW, Bunting BA, Christensen DB. The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43(2):173–84.
Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30(3):238–43.
Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the fremantle diabetes study. Diabetes Care 2005;28(4):771–6.
Snella KA. Pharmacy-and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (Wash) 2006;46(3):370–7.
Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract 2006;75(3):339–47.
Granås AG, Berg CL. Type 2-diabetes: Hva kan apotekene bidra med? [type 2 diabetes: what can the pharmacies contribute]. Diabetes Forum 2004;1:36–7.
Norges Diabetesforbund [homepage on the internet]. The role of Norwegian pharmacies in the prevention and treatment of diabetes. Joint declaration from the Norwegian Diabetes Association, the Norwegian Pharmacy Association and the Interest group Diabetes in the Pharmacy. http://www.diabetes.no/index.asp?id=26256 (27 Jul 2005).
Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: A critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract 2005 2005;(4):231–40.
Lange MH, Granas AG. [Pharmacies before and after the new legislation]. Tidsskr Nor Laegeforen 2003;123(22):3248–49.
Norges Apotekerforening. Apotek og legemidler 2006 - bransjestatistikk om apotekenes virksomhet og rammevilkår [Pharmacy and drugs 2006]. Oslo: Norges Apotekerforening; 2006. ISBN 82-990739-2-8.
Norges Apotekerforening [homepage on the internet]. Bransjestatistikk [Trade statistics]. http://www.apotek.no (28 Jul 2005).
Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy (New York) 2005;75(1):9–17.
Tine Dommerud [homepage on the internet]. Apotek som miniklinikker [Pharmacies as mini-clinics]. http://www.dagensmedisin.no/nyheter/ (23 May 2007).
Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990;7(4):360.
Claudi T, Midthjel K, Cooper J, Daae C, Furuseth K, Hanssen KF [monograph on the internet]. NSAMs handlingsprogram for diabetes [NSAMs’ diabetes plan of action]. http://www.nsamdiabetes.no/ (26 Jul 2005) .
Ministry of health and care services [report on the internet]. [National strategy for the area of diabetes 2006–2010]. http://www.regjeringen.no/en/dep/hod/Documents/rapporter_planer/rapporter/2006/Nasjonal-strategi-for-diabetesomradet-2006–2010.html?id=106611 (30 May 2007).
Stewart D, O’Shea J, McCaig D. Agreement of practitioners with the recommendations of the ‘Guidelines for Community Pharmacists on the Care of Patients with Diabetes’. J Soc Adm Pharm 2003;20(1):13–7.
Westerlund LLTBrH. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 2006;40(6):1162–9.
Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005;25(1):96–109.
Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai 2005;88(Suppl)4:S134–41.
Masood N, Armour C, Krass I. Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. J Soc Adm Pharm 2002;19(5):170–9.
Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother 2005;39(9):1539–41.
Department of Health [homepage on the internet]. Dawn of new era for pharmacy. http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en?CONTENT_ID=4107503&chk=SL9Ji9 (4 Oct 2006).
Standards of medical care in diabetes–2006. Diabetes Care 2006; 29(Suppl)1:S4–42.
Abduelkarem AR, Sackville MA, Morgan RM, Sackville MP, Hildreth AJ. Views and practices of community pharmacists regarding services for people with type 2 diabetes. Int J Pharm Pract 2003;11:161–8.
Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc (Wash) 2000;40(6):773–9.
Heaton PC. Patients’ need for more counseling on diet, exercise, and smoking cessation: results from the National Ambulatory Medical Care Survey. J Am Pharm Assoc 2006;46(3):364–9.
Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother 2001;35(7–8):841–5.
Storimans MJ, Klungel OH, Talsma H, Bouvy ML, de Blaey CJ. Collaborative services among community pharmacies for patients with diabetes. Ann Pharmacother 2005;39(10):1647–53.
The authors would like to thank Finn Steen for help with the web questionnaire design and administration. Work presented as an abstract at the 2nd Nordic Social Pharmacy and Health Services Research Conference, Lahti, Finland, November 2005.
Rights and permissions
About this article
Cite this article
Kjome, R.L.S., Sandberg, S. & Granås, A.G. Diabetes care in Norwegian pharmacies: a descriptive study. Pharm World Sci 30, 191–198 (2008). https://doi.org/10.1007/s11096-007-9164-5
- Pharmacy services
- Diabetes Mellitus
- Glucose monitoring